Optimising oral PrEP while awaiting long-acting cabotegravir. (2023)

First Author: McCormack S

Attributed to: Blood borne viruses funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2352-3018(23)00231-x

PubMed Identifier: 37783220

Publication URI: http://europepmc.org/abstract/MED/37783220

Type: Journal Article/Review

Volume: 10

Parent Publication: The lancet. HIV

Issue: 11

ISSN: 2352-3018